Skip to main content
Bemcentinib NSCLC

Bemcentinib - Keytruda Combination in NSCLC

FDA Grants Fast Track Designation to Bemcentinib Combo in Advanced NSCLC

Liver News Updates

Immunotherapy improves survival in cholangiocarcinoma and other biliary tract cancers.

Immunotherapy improves survival in cholangiocarcinoma and other biliary tract cancers.

Liver Cancer Connect is a unique resource that brings patients, caregivers, advocates and experts together - individuals benefit from a blend of expert-authored news and educational programming alongside a robust social network, providing insight into symptoms, diagnosis, and treatment and the support of other individuals being treated at some of the best cancer centers. Liver Cancer Connect offers users expert authored clinically-reviewed information and the perspective of their peers in a safe, objective space, helping to ensure they become empowered in their healthcare journey. Search the over 7000 articles on the management of cancer.